Evidence map›Paper›PMID 32277149›Full record

ArticleScientific reports2020

Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements.

Kristian C Becker, Lydia Coulter Kwee, Megan L Neely, Elizabeth Grass, Joseph A Jakubowski, Keith A A Fox, Harvey D White, Simon G Gregory, Paul A Gurbel, Leonardo de Pinto Carvalho and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Kristian C BeckerIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Lydia Coulter KweeDuke Molecular Physiology Institute, Durham, NC, USA.
Megan L NeelyDuke Clinical Research Institute, Durham, NC, USA.
Elizabeth GrassDuke Molecular Physiology Institute, Durham, NC, USA.
Joseph A JakubowskiEli Lilly and Company, Indianapolis, IN, USA.
Keith A A FoxUniversity of Edinburgh, Edinburgh, UK.
Harvey D WhiteGreen Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.
Simon G GregoryDuke Molecular Physiology Institute, Durham, NC, USA.
Paul A GurbelInova Heart & Vascular Institute, Falls Church, VA, USA.
Leonardo de Pinto CarvalhoAlbert Einstein Hospital, Sao Paolo, Brasil.
Richard C BeckerUniversity of Cincinnati, Cincinnati, Ohio, USA.
E Magnus OhmanDuke Clinical Research Institute, Durham, NC, USA.
Matthew T RoeDuke Clinical Research Institute, Durham, NC, USA.
Svati H ShahDuke Molecular Physiology Institute, Durham, NC, USA.
Mark Y ChanNational University of Singapore, Singapore, Singapore. mark_chan@nuhs.edu.sg.
Clinical Research Institute · USDuke Medical Center · USAuckland City Hospital · NZDuke University · USEli Lilly (United States) · USHospital Israelita Albert Einstein · BRIcahn School of Medicine at Mount Sinai · USNational University of Singapore · SGUniversity of Cincinnati · USUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Changes in platelet physiology are associated with simultaneous changes in microRNA concentrations, suggesting a role for microRNA in platelet regulation. Here we investigated potential associations between microRNA and platelet reactivity (PR), a marker of platelet function, in two cohorts following a non-ST elevation acute coronary syndrome (NSTE-ACS) event. First, non-targeted microRNA concentrations and PR were compared in a case (N = 77) control (N = 76) cohort within the larger TRILOGY-ACS trial. MicroRNA significant in this analysis plus CVD-associated microRNAs from the literature were then quantified by targeted rt-PCR in the complete TRILOGY-ACS cohort (N = 878) and compared with matched PR samples. Finally, microRNA significant in the non-targeted & targeted analyses were verified in an independent post NSTE-ACS cohort (N = 96). From the non-targeted analysis, 14 microRNAs were associated with PR (Fold Change: 0.91-1.27, p-value: 0.004-0.05). From the targeted analysis, five microRNAs were associated with PR (Beta: -0.09-0.22, p-value: 0.004-0.05). Of the 19 significant microRNAs, three, miR-15b-5p, miR-93 and miR-126, were consistently associated with PR in the TRILOGY-ACS and independent Singapore post-ACS cohorts, suggesting the measurement of circulating microRNA concentrations may report on dynamic changes in platelet biology following a cardiovascular ischemic event.

Indexed as

Acute Coronary SyndromeAgedBlood PlateletsCase-Control StudiesCirculating MicroRNAFemaleGene Expression ProfilingHumansMaleMiddle AgedPlatelet AggregationSingaporeCirculating MicroRNA

Identifiers

PMID32277149
PMCPMC7148370
OpenAlexW3015254376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.